These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 328220)

  • 1. [The biguanides in the treatment of late florid diabetes of recent diagnosis: controlled trial of delayed-action buformin and placebo].
    Angeli G; Baraldi B; Ciaramelli F
    Clin Ter; 1977 Jun; 81(5):453-62. PubMed ID: 328220
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of a clinical study of a group of hospitalized diabetics under treatment with depot buformin].
    Durante F; Scaffidi A; Rotolo G; Rini GB
    Minerva Med; 1978 May; 69(24):1665-72. PubMed ID: 662170
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical use of a new hypoglycemic agent: buformin].
    Leone S; Modicano V; Scapellato L
    Clin Ter; 1976 Sep; 78(6):527-35. PubMed ID: 1017159
    [No Abstract]   [Full Text] [Related]  

  • 4. [Vitamin B 12 absorption disorders in diabetic patients treated with adebit].
    Keszthelyi B; Tóth A; Novotny S; Fónay K; Jávor T; Past T; Bero T
    Orv Hetil; 1976 Apr; 117(16):963-4. PubMed ID: 1272562
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood lactate and biguanide therapy: comparison between phenformin, metformin and buformin in 408 senile diabetics].
    Bruneder H; Klein HJ
    Acta Med Austriaca; 1978; 5(3):88-90. PubMed ID: 752220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vitamin B12-level in serum of diabetics receiving long-term buformin therapy].
    Müller P; Fischer H; Sorger D
    Z Gesamte Inn Med; 1981 Mar; 36(6):226-8. PubMed ID: 7257460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Biguanides: reasons for withdrawal of drugs and remaining indications].
    Bolzano K
    Acta Med Austriaca; 1978; 5(3):85-8. PubMed ID: 752219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sustained-release formulation of buformin hydrochloride.
    Sawayanagi Y; Sonobe T; Kawata H; Nambu N; Nagai T
    Chem Pharm Bull (Tokyo); 1984 Mar; 32(3):1049-54. PubMed ID: 6744479
    [No Abstract]   [Full Text] [Related]  

  • 9. [Indications and contraindications to the diabetes mellitus therapy by biguanide derivatives in the light of the metabolic and epidemiologic studies (author's transl)].
    Tatoń J; Kowalik-Borówka E
    Przegl Lek; 1979; 36(7):553-7. PubMed ID: 504704
    [No Abstract]   [Full Text] [Related]  

  • 10. Dichloracetate in biguanide-induced lacticacidosis.
    Irsigler K; Kaspar L; Kritz H
    Lancet; 1977 Nov; 2(8046):1026-7. PubMed ID: 72918
    [No Abstract]   [Full Text] [Related]  

  • 11. [The risk of lacticate acidosis: a comparison of the 3 biguanides in treatment of diabetics (authors' transl)].
    Irsigler K; Kritz H; Regal H; Foltin E
    Wien Klin Wochenschr; 1978 May; 90(10):332-7. PubMed ID: 654296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biguanides in treatment of obesity. II. Controlled clinical research with placebos, metformin and phenformin in obesity with normal and reduced tolerance to carbohydrates].
    Cucurachi L; Strata A; Zuliani U; Cucurachi P; Dell'Anna A
    Clin Ter; 1968 Nov; 47(3):233-45. PubMed ID: 4911791
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical experience with the oral administration of the antidiabetic buformin.
    Sieberová R
    Rev Czech Med; 1971; 17(4):219-21. PubMed ID: 5122079
    [No Abstract]   [Full Text] [Related]  

  • 14. Biguanides. Mode of action and role in the up-to-date treatment of diabetes mellitus.
    Fövényi J
    Ther Hung; 1971; 19(2):43-8. PubMed ID: 5172874
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of buformin on the metabolism of skeletal muscles in diabetic rats].
    Strohfeldt P; Strubel-Obermaier U; Kettl H
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():771-4. PubMed ID: 142394
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of biguanide therapy on lactate metabolism during graded submaximal ergometric testing].
    Pilger E; Schmid P; Goebel R
    Acta Med Austriaca; 1978; 5(3):91-5. PubMed ID: 752221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A contribution to the study of the effect of bigvanides in the skeletal muscle of diabetics (author's transl)].
    Vondra K; Bass A; Brunová E; Slabochová Z; Teisinger J; Vítek V
    Cas Lek Cesk; 1978 Jul; 117(29-30):892-4. PubMed ID: 688313
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical evaluation of Silubin-retard].
    Miturzyńska-Stryjecka H; Widomska-Czekajska T
    Pol Tyg Lek; 1972 Jun; 27(26):1003-6. PubMed ID: 5068985
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic action of a new dimethylbiguanide salt].
    Linquette M; Fourlinnie JC; Benoit G
    Lille Med; 1974 Feb; 19(2):213-7. PubMed ID: 4603917
    [No Abstract]   [Full Text] [Related]  

  • 20. [Research on the euglycemic effect of a new, delayed-action phenformin in florid diabetic patients during oral glucose tolerance test].
    Vailati G; Cuttica F; Montini M; Rebba A; Pagani G
    Clin Ter; 1974 Jan; 68(2):149-70. PubMed ID: 4596250
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.